COVID-19诊断和治疗的新方法

N. Djumaeva
{"title":"COVID-19诊断和治疗的新方法","authors":"N. Djumaeva","doi":"10.14299/ijser.2020.09.04","DOIUrl":null,"url":null,"abstract":"Although several clinical trials are now underway to test possible therapies, the issue of reliable \n therapy for COVID-19 remains debatable. We report here the new approach to individual \n selection of Dexamethasone and Ribavirin doses used in COVID-19 therapy. For the first time \n “the device for transmission of Ribavirin pharmacological properties to a human body” was used \n to eliminate the virus from the COVID-19 patients' body quickly and safely. Dexamethasone \n and Ribavirin are included in the WHO List of Essential Medicines. The proposed methods \n of “medicament testing” as well as the application of “the device for transmission of Ribavirin \n pharmacological properties to a human body” need further investigation for possible benefits for \n coronavirus infection therapy.","PeriodicalId":14354,"journal":{"name":"International journal of scientific and engineering research","volume":"52 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"New Approaches to Diagnostics and Therapy for COVID-19\",\"authors\":\"N. Djumaeva\",\"doi\":\"10.14299/ijser.2020.09.04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although several clinical trials are now underway to test possible therapies, the issue of reliable \\n therapy for COVID-19 remains debatable. We report here the new approach to individual \\n selection of Dexamethasone and Ribavirin doses used in COVID-19 therapy. For the first time \\n “the device for transmission of Ribavirin pharmacological properties to a human body” was used \\n to eliminate the virus from the COVID-19 patients' body quickly and safely. Dexamethasone \\n and Ribavirin are included in the WHO List of Essential Medicines. The proposed methods \\n of “medicament testing” as well as the application of “the device for transmission of Ribavirin \\n pharmacological properties to a human body” need further investigation for possible benefits for \\n coronavirus infection therapy.\",\"PeriodicalId\":14354,\"journal\":{\"name\":\"International journal of scientific and engineering research\",\"volume\":\"52 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of scientific and engineering research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14299/ijser.2020.09.04\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of scientific and engineering research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14299/ijser.2020.09.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

尽管目前正在进行几项临床试验,以测试可能的治疗方法,但COVID-19的可靠治疗问题仍存在争议。我们在此报告了用于COVID-19治疗的地塞米松和利巴韦林剂量个体选择的新方法。首次使用“利巴韦林药理学特性人体传播装置”,快速安全地将病毒从COVID-19患者体内清除。地塞米松和利巴韦林被列入世卫组织基本药物清单。提出的“药物测试”方法以及“利巴韦林药理学特性传播到人体的装置”的应用需要进一步研究,以确定对冠状病毒感染治疗的可能益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
New Approaches to Diagnostics and Therapy for COVID-19
Although several clinical trials are now underway to test possible therapies, the issue of reliable therapy for COVID-19 remains debatable. We report here the new approach to individual selection of Dexamethasone and Ribavirin doses used in COVID-19 therapy. For the first time “the device for transmission of Ribavirin pharmacological properties to a human body” was used to eliminate the virus from the COVID-19 patients' body quickly and safely. Dexamethasone and Ribavirin are included in the WHO List of Essential Medicines. The proposed methods of “medicament testing” as well as the application of “the device for transmission of Ribavirin pharmacological properties to a human body” need further investigation for possible benefits for coronavirus infection therapy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信